Overview of Dr. Tripathi
Dr. Abhishek Tripathi is an oncologist in Duarte, CA and is affiliated with City of Hope Comprehensive Cancer Center. He received his medical degree from Maulana Azad Medical College and has been in practice 8 years. He is one of 222 doctors at City of Hope Comprehensive Cancer Center who specialize in Oncology. He has more than 80 publications and over 500 citings.
Office
1500 East Duarte Road
Duarte, CA 91010
Education & Training
UMass Chan - BaystateFellowship, Hematology and Medical Oncology, 2014 - 2017
UMass Chan Medical SchoolResidency, Internal Medicine, 2011 - 2014
Maulana Azad Medical CollegeClass of 2009
Certifications & Licensure
CA State Medical License 2022 - 2026
OK State Medical License 2017 - 2023
MA State Medical License 2011 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Merit Award American Society of Clinical Oncology, 2017
- Chief Fellow Baystate Medical Center, Tufts University, 2016-2017
Clinical Trials
- Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma Start of enrollment: 2020 Feb 17
- Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma Start of enrollment: 2020 Jul 22
Publications & Presentations
PubMed
- 56 citationsDifferential Protein Kinase C-dependent Modulation of Kv7.4 and Kv7.5 Subunits of Vascular Kv7 ChannelsLioubov I. Brueggemann, Alexander R Mackie, Leanne L. Cribbs, Jessica Freda, Abhishek Tripathi
The Journal of Biological Chemistry. 2014-01-24 - 38 citationsA New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.Ali Raza Khaki, Ang Li, Leonidas Nikolaos Diamantopoulos, Natalie J. Miller, Lucia Carril-Ajuria
European Urology Oncology. 2021-06-01 - 4 citationsGenomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors.Neal S Chawla, Nicolas Sayegh, Nishita Tripathi, Ameish Govindarajan, Zeynep B Zengin
Clinical Genitourinary Cancer. 2023-02-01
Lectures
- Prognostic significance of CD73 expression in localized renal cell carcinoma (RCC).ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- NT5E expression and the immune landscape of prostate cancer (PC): An analysis from The Cancer Genome Atlas database.ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
Press Mentions
Aravive Reports Fourth Quarter and Twelve Months Ended December 31, 2019 Financial Results and Provides Recent Corporate UpdatesMarch 27th, 2020
ASCO 2023: Record Numbers & the Big ShowMay 31st, 2023- MedPage Today – Abhishek Tripathi, MD, on Eligibility Criteria in Advanced Urothelial Cancer TrialsJuly 13th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
